Free Trial
NASDAQ:FBIO

Fortress Biotech (FBIO) Stock Price, News & Analysis

Fortress Biotech logo
$1.96 +0.03 (+1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$2.00 +0.04 (+2.30%)
As of 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fortress Biotech Stock (NASDAQ:FBIO)

Key Stats

Today's Range
$1.91
$1.96
50-Day Range
$1.71
$2.13
52-Week Range
$1.33
$2.36
Volume
108,928 shs
Average Volume
263,005 shs
Market Capitalization
$57.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
Consensus Rating
Buy

Company Overview

Fortress Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

FBIO MarketRank™: 

Fortress Biotech scored higher than 52% of companies evaluated by MarketBeat, and ranked 528th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fortress Biotech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Fortress Biotech has received no research coverage in the past 90 days.

  • Read more about Fortress Biotech's stock forecast and price target.
  • Earnings Growth

    Earnings for Fortress Biotech are expected to grow in the coming year, from ($3.28) to ($1.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fortress Biotech is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fortress Biotech is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    14.10% of the float of Fortress Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Fortress Biotech has a short interest ratio ("days to cover") of 14.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Fortress Biotech has recently decreased by 4.79%, indicating that investor sentiment is improving.
  • Dividend Yield

    Fortress Biotech does not currently pay a dividend.

  • Dividend Growth

    Fortress Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.10% of the float of Fortress Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Fortress Biotech has a short interest ratio ("days to cover") of 14.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Fortress Biotech has recently decreased by 4.79%, indicating that investor sentiment is improving.
  • News Sentiment

    Fortress Biotech has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Fortress Biotech this week, compared to 1 article on an average week.
  • Search Interest

    9 people have searched for FBIO on MarketBeat in the last 30 days. This is an increase of 350% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Fortress Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Fortress Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.90% of the stock of Fortress Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    96.51% of the stock of Fortress Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Fortress Biotech's insider trading history.
Receive FBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter.

FBIO Stock News Headlines

Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.
Fortress Biotech (FBIO) Expected to Announce Quarterly Earnings on Tuesday
FBIO Fortress Biotech, Inc. - Seeking Alpha
See More Headlines

FBIO Stock Analysis - Frequently Asked Questions

Fortress Biotech's stock was trading at $2.03 on January 1st, 2025. Since then, FBIO shares have decreased by 3.9% and is now trading at $1.95.

Fortress Biotech, Inc. (NASDAQ:FBIO) issued its quarterly earnings data on Monday, March, 31st. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, beating analysts' consensus estimates of ($0.79) by $0.53. The biopharmaceutical company had revenue of $15.12 million for the quarter, compared to the consensus estimate of $16.30 million. Fortress Biotech had a negative trailing twelve-month return on equity of 4,712.53% and a negative net margin of 71.24%.
Read the conference call transcript
.

Shares of Fortress Biotech reverse split on the morning of Tuesday, October 10th 2023.The 1-15 reverse split was announced on Monday, October 9th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Fortress Biotech's top institutional shareholders include Shikiar Asset Management Inc. (0.94%), Envestnet Asset Management Inc. (0.57%), 180 Wealth Advisors LLC (0.31%) and Atria Investments Inc (0.30%). Insiders that own company stock include Lindsay A Md Rosenwald, Dov Klein and David Jin.
View institutional ownership trends
.

Shares of FBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fortress Biotech investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), KALA BIO (KALA), Ovid Therapeutics (OVID), Lipocine (LPCN) and Comtech Telecommunications (CMTL).

Company Calendar

Today
8/14/2025
Last Earnings
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:FBIO
CIK
1429260
Employees
170
Year Founded
N/A

Price Target and Rating

High Price Target
$26.00
Low Price Target
$16.00
Potential Upside/Downside
+971.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46 million
Net Margins
-71.24%
Pretax Margin
-183.81%
Return on Equity
-4,712.53%
Return on Assets
-27.67%

Debt

Debt-to-Equity Ratio
1.74
Current Ratio
1.72
Quick Ratio
1.55

Sales & Book Value

Annual Sales
$57.67 million
Price / Sales
1.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-32.67

Miscellaneous

Outstanding Shares
29,570,000
Free Float
21,320,000
Market Cap
$57.96 million
Optionable
Optionable
Beta
1.76

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:FBIO) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners